Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ADVANTEST, 11% Increase in Net Income, Update Record High for Second Consecutive Term
6857 ADVANTEST CORPORATION 【IFRS】
Earnings ReportADVANTEST CORPORATION <6857> [TSE Prime] announced its financial results (based on IFRS) after the market closed on April 25th (15:30). The consolidated net income for the fiscal year ending March 2025 surged by 2.6 times that of the previous term, reaching 161 billion yen. In the fiscal year ending March 2026, the profit is expected to grow by 11.1% to 179 billion yen, marking the second consecutive term of record-high profits.
At the same time, the company has left the annual dividend for the current term undetermined.
In the most recent three-month period, from January to March (4Q), the consolidated net income surged 2.6 times that of the same period last year, reaching 39.9 billion yen. The operating profit margin jumped from 14.4% in the same period last year to 27.6%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 560,191 | 167,687 | 171,270 | 130,400 | 174.4 | 33.75 | Apr 26, 2023 | IFRS |
Mar, 2024 | 486,507 | 81,628 | 78,170 | 62,290 | 84.5 | 34.25 | Apr 26, 2024 | IFRS |
Mar, 2025 | 779,707 | 228,161 | 224,774 | 161,177 | 218.7 | 39 | Apr 25, 2025 | IFRS |
YoY | +60.3% | +179.5% | +187.5% | +158.8% | +158.9% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Guidance | 740,000 | 226,000 | 225,000 | 167,500 | 228.3 | 39 | Jan 29, 2025 | IFRS |
Mar, 2025 Results | 779,707 | 228,161 | 224,774 | 161,177 | 218.7 | 39 | Apr 25, 2025 | IFRS |
Revision Rate | +5.4% | +1.0% | -0.1% | -3.8% | -4.2% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 | 329,206 | 94,859 | 92,645 | 69,343 | 93.9 | 19 | Oct 30, 2024 | IFRS |
Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | - | Apr 25, 2025 | IFRS |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2024 | 486,507 | 81,628 | 78,170 | 62,290 | 84.5 | 34.25 | Apr 26, 2024 | IFRS |
Mar, 2025 | 779,707 | 228,161 | 224,774 | 161,177 | 218.7 | 39 | Apr 25, 2025 | IFRS |
Mar, 2026 Guidance | 755,000 | 242,000 | 240,000 | 179,000 | 244.7 | - | Apr 25, 2025 | IFRS |
YoY | -3.2% | +6.1% | +6.8% | +11.1% | +11.9% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 135,763 | 19,529 | 18,603 | 15,147 | 20.5 | 14.4 | Apr 26, 2024 | IFRS |
Apr - Jun, 2024 | 138,725 | 31,325 | 31,930 | 23,873 | 32.4 | 22.6 | Jul 31, 2024 | IFRS |
Jul - Sep, 2024 | 190,481 | 63,534 | 60,715 | 45,470 | 61.6 | 33.4 | Oct 30, 2024 | IFRS |
Oct - Dec, 2024 | 218,152 | 69,267 | 70,547 | 51,867 | 70.3 | 31.8 | Jan 29, 2025 | IFRS |
Jan - Mar, 2025 | 232,349 | 64,035 | 61,582 | 39,967 | 54.2 | 27.6 | Apr 25, 2025 | IFRS |
YoY | +71.1% | +227.9% | +231.0% | +163.9% | +164.0% |
Related Articles
Takatori, First Half Ordinary Profit Revised Upward by 2.3 times
Imamura Securities, 32% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
AXYZ, The Current Fiscal Year Ordinary Profit Revised Upward by 36%
TOHO LAMAC, Jan-Mar (1Q) Ordinary Profit Turns to Loss
Kawagishi Bridge Works, First Half Ordinary Profit Revised Upward to an Unexpected 8% Increase
Astellas Pharma, Last Fiscal Year's Net Income Unexpectedly Increases, 2.6 times Increase in Net Income for The Current Fiscal Year, Dividend Raised by 4 yen
TORICO, Last Fiscal Year Net Income Loss Widened in Downward Revision
ANRITSU, 19% Increase in Net Income for The Current Fiscal Year
ZENITAKA, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 2% Increase, Dividend Revised Upward by 20 yen
TORII PHARMA, Jan-Mar (1Q) Ordinary Profit Increases by 59%